A detailed history of Fairfield Financial Advisors, LTD transactions in Amgen Inc stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 8,284 shares of AMGN stock, worth $2.67 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
8,284
Previous 8,091 2.39%
Holding current value
$2.67 Million
Previous $2.53 Billion 5.58%
% of portfolio
0.91%
Previous 0.74%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$309.38 - $337.38 $59,710 - $65,114
193 Added 2.39%
8,284 $2.67 Billion
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $2.13 Million - $2.58 Million
8,091 New
8,091 $2.53 Billion
Q4 2023

Nov 04, 2024

BUY
$255.7 - $288.46 $77,477 - $87,403
303 Added 4.33%
7,294 $2.1 Billion
Q3 2023

Nov 04, 2024

BUY
$218.65 - $271.46 $140,810 - $174,820
644 Added 10.15%
6,991 $1.88 Billion
Q2 2023

Nov 04, 2024

SELL
$214.27 - $253.37 $415,040 - $490,777
-1,937 Reduced 23.38%
6,347 $1.41 Billion
Q1 2023

Nov 04, 2024

SELL
$225.79 - $275.2 $775,588 - $945,312
-3,435 Reduced 41.47%
4,849 $1.17 Billion
Q4 2022

Oct 07, 2024

BUY
$229.03 - $291.01 $88,863 - $112,911
388 Added 10.1%
4,230 $1.11 Billion
Q3 2022

Oct 07, 2024

SELL
$224.46 - $253.15 $953,730 - $1.08 Million
-4,249 Reduced 52.52%
3,842 $866 Million
Q2 2022

Oct 07, 2024

SELL
$230.71 - $256.74 $1.09 Million - $1.21 Million
-4,718 Reduced 58.31%
3,373 $821 Million
Q1 2022

Oct 07, 2024

SELL
$219.27 - $242.57 $1.01 Million - $1.12 Million
-4,605 Reduced 56.92%
3,486 $843 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fairfield Financial Advisors, LTD Portfolio

Follow Fairfield Financial Advisors, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.